{"keywords": [{"value": "Pfizer Inc", "rank": "1", "is_major": "Y", "name": "organizations"}, {"value": "Allergan Inc", "rank": "2", "is_major": "Y", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "rank": "3", "is_major": "N", "name": "subject"}, {"value": "Mergers, Acquisitions and Divestitures", "rank": "4", "is_major": "N", "name": "subject"}], "headline": {"print_headline": "Pfizer Bid for Allergan Has Its Eyes on Ireland", "main": "Pfizer Bid for Allergan Has Its Eyes on Ireland"}, "byline": {"original": "By MICHAEL J. de la MERCED and LESLIE PICKER", "person": [{"middlename": "J.", "organization": "", "lastname": "de la MERCED", "role": "reported", "firstname": "Michael", "rank": 1}, {"rank": 2, "role": "reported", "organization": "", "lastname": "PICKER", "firstname": "Leslie"}]}, "web_url": "http://www.nytimes.com/2015/10/30/business/dealbook/allergan-pfizer-deal.html", "source": "The New York Times", "subsection_name": "DealBook", "slideshow_credits": null, "type_of_material": "News", "_id": "563227a838f0d806a6b07515", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/10/30/business/db-drug-web2/db-drug-web2-thumbWide.jpg"}, "type": "image", "width": 190, "url": "images/2015/10/30/business/db-drug-web2/db-drug-web2-thumbWide.jpg"}, {"height": 401, "subtype": "xlarge", "legacy": {"xlargeheight": "401", "xlargewidth": "600", "xlarge": "images/2015/10/30/business/db-drug-web2/db-drug-web2-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2015/10/30/business/db-drug-web2/db-drug-web2-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnailheight": "75", "thumbnail": "images/2015/10/30/business/db-drug-web2/db-drug-web2-thumbStandard.jpg"}, "type": "image", "width": 75, "url": "images/2015/10/30/business/db-drug-web2/db-drug-web2-thumbStandard.jpg"}], "pub_date": "2015-10-30T00:00:00Z", "print_page": "1", "section_name": "Business Day", "word_count": "1090", "blog": [], "news_desk": "Business", "snippet": "Pfizer, one of America\u2019s oldest drug makers, is again looking to renounce its corporate citizenship by buying a foreign rival.", "document_type": "article", "abstract": "Pfizer, one of America\u2019s oldest drug makers, and Allergan, drug maker based in Ireland, confirm that they are considering a merger; takeover would be largest-ever in health care industry.", "lead_paragraph": "Pfizer, one of America\u2019s oldest drug makers, is again looking to renounce its corporate citizenship by buying a foreign rival."}